Ball Corp: BofA Global Research cuts price objective to $68 from $75
BALL•BofA Global Research cut its price objective for Ball Corp to $68 from $75.
Related News
ArriVent's lung cancer treatment fails late-stage trial
AVBP•
Charles River partners with Autolomous to roll out Apollo Orchestrate lab execution system
CRL•
Star Gold names Tom Power as chief operating officer
SRGZ•
Sun Life research shows 69% of Canadian small business owners would take bolder decisions with greater financial security
SLF•
BlackRock report shows 68% of Canadian workplace savers worry about outliving retirement savings
BLK•